Clinical Trials

How pharma is working to develop efficient and patient-centric trials.

A trial for a new immunotherapy is seeing incredible results for rectal cancer patients.

The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.

Clinical trials suffer from heavy dropout rates. Perhaps the answer is a little care and attention.

What is going on with Aduhelm? And why is the drug seen by some to be controversial?

A report from Clarivate has tipped 7 drugs for potential blockbuster status in 2022. Here’s what makes them stand out.

A 2000-participant study in Europe has examined how drugs – and combinations of drugs – can affect the microbiota in our gut.

Why the industry needs to finally wake up to the real-life benefits of real-world data.

An interview with Ken Gruber of Endevica Bio on his work producing a treatment for cachexia, a wasting condition common in late-stage cancer.

New ICH guideline revisions are imminent. Sue Batchelor of Cmed shares her thoughts on how sponsors and CROs can prepare themselves.